instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Abdominal discomfort'? | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | Recovered | ReactionOutcome | CC BY | 34223152 | 19,581,896 | 2021-06 |
What was the outcome of reaction 'Acute kidney injury'? | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | Recovered | ReactionOutcome | CC BY | 34223152 | 19,581,896 | 2021-06 |
What was the outcome of reaction 'Dehydration'? | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | Recovered | ReactionOutcome | CC BY | 34223152 | 19,581,896 | 2021-06 |
What was the outcome of reaction 'Vomiting'? | Compassionate use of cefiderocol for carbapenem-resistant Acinetobacter baumannii prosthetic joint infection.
Cefiderocol is a recently licensed novel siderophore-conjugated cephalosporin stable to hydrolysis by serine and MBLs. It has been successfully used to treat Enterobacterales infections and is approved for the ... | Recovered | ReactionOutcome | CC BY | 34223152 | 19,581,896 | 2021-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | A case report: percutaneous management of high-output heart failure from iatrogenic aortocoronary venous grafting to the coronary sinus.
BACKGROUND
Aortocoronary arteriovenous fistula (ACAVF) due to iatrogenic bypass grafting to a cardiac vein is an exceedingly rare complication resulting from coronary artery bypass gr... | LISINOPRIL | DrugsGivenReaction | CC BY | 34224036 | 19,683,921 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Dieulafoy's lesion in the cecum: A rare case report presentation.
Dieulafoy's lesion is a rare entity, normally present in the stomach and more rarely in the colon, and it is responsible for 1% to 5% of acute gastrointestinal bleeding cases. Its true incidence may be underrated, since most cases are asymptomatic and di... | APIXABAN, ASPIRIN | DrugsGivenReaction | CC BY-NC-ND | 34225059 | 19,775,604 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoglobin decreased'. | Dieulafoy's lesion in the cecum: A rare case report presentation.
Dieulafoy's lesion is a rare entity, normally present in the stomach and more rarely in the colon, and it is responsible for 1% to 5% of acute gastrointestinal bleeding cases. Its true incidence may be underrated, since most cases are asymptomatic and di... | APIXABAN, ASPIRIN | DrugsGivenReaction | CC BY-NC-ND | 34225059 | 19,775,604 | 2021-07 |
What was the outcome of reaction 'Gastrointestinal haemorrhage'? | Dieulafoy's lesion in the cecum: A rare case report presentation.
Dieulafoy's lesion is a rare entity, normally present in the stomach and more rarely in the colon, and it is responsible for 1% to 5% of acute gastrointestinal bleeding cases. Its true incidence may be underrated, since most cases are asymptomatic and di... | Recovering | ReactionOutcome | CC BY-NC-ND | 34225059 | 19,775,604 | 2021-07 |
What was the outcome of reaction 'Haemoglobin decreased'? | Dieulafoy's lesion in the cecum: A rare case report presentation.
Dieulafoy's lesion is a rare entity, normally present in the stomach and more rarely in the colon, and it is responsible for 1% to 5% of acute gastrointestinal bleeding cases. Its true incidence may be underrated, since most cases are asymptomatic and di... | Not recovered | ReactionOutcome | CC BY-NC-ND | 34225059 | 19,775,604 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fall'. | Severe restless legs syndrome in a family with Alport syndrome.
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterized by an urge to move the legs during inactivity, especially at evening-night. RLS is highly prevalent in patients with kidney failure and have an impact on quality of life... | CLONAZEPAM, PRAMIPEXOLE, ROTIGOTINE | DrugsGivenReaction | CC BY | 34225668 | 20,415,181 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fracture'. | Severe restless legs syndrome in a family with Alport syndrome.
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterized by an urge to move the legs during inactivity, especially at evening-night. RLS is highly prevalent in patients with kidney failure and have an impact on quality of life... | CLONAZEPAM, PRAMIPEXOLE, ROTIGOTINE | DrugsGivenReaction | CC BY | 34225668 | 20,415,181 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Restless legs syndrome'. | Severe restless legs syndrome in a family with Alport syndrome.
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterized by an urge to move the legs during inactivity, especially at evening-night. RLS is highly prevalent in patients with kidney failure and have an impact on quality of life... | CLONAZEPAM, PRAMIPEXOLE, ROTIGOTINE | DrugsGivenReaction | CC BY | 34225668 | 20,415,181 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sleep attacks'. | Severe restless legs syndrome in a family with Alport syndrome.
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterized by an urge to move the legs during inactivity, especially at evening-night. RLS is highly prevalent in patients with kidney failure and have an impact on quality of life... | CLONAZEPAM, PRAMIPEXOLE, ROTIGOTINE | DrugsGivenReaction | CC BY | 34225668 | 20,415,181 | 2021-07-05 |
What was the dosage of drug 'ROTIGOTINE'? | Severe restless legs syndrome in a family with Alport syndrome.
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterized by an urge to move the legs during inactivity, especially at evening-night. RLS is highly prevalent in patients with kidney failure and have an impact on quality of life... | 3 mg (milligrams). | DrugDosage | CC BY | 34225668 | 20,415,181 | 2021-07-05 |
What was the outcome of reaction 'Restless legs syndrome'? | Severe restless legs syndrome in a family with Alport syndrome.
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterized by an urge to move the legs during inactivity, especially at evening-night. RLS is highly prevalent in patients with kidney failure and have an impact on quality of life... | Recovering | ReactionOutcome | CC BY | 34225668 | 20,415,181 | 2021-07-05 |
What was the outcome of reaction 'Sleep attacks'? | Severe restless legs syndrome in a family with Alport syndrome.
Restless legs syndrome (RLS) is a common sleep-related movement disorder characterized by an urge to move the legs during inactivity, especially at evening-night. RLS is highly prevalent in patients with kidney failure and have an impact on quality of life... | Recovering | ReactionOutcome | CC BY | 34225668 | 20,415,181 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anuria'. | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, METHYLPREDNISOLONE ACETATE, METOPROLOL SUCCINATE, NIVOLUMAB, PANITUMUMAB, PANTOPRAZOLE SODIUM | DrugsGivenReaction | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiogenic shock'. | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34225811 | 19,602,584 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, METHYLPREDNISOLONE ACETATE, METOPROLOL SUCCINATE, NIVOLUMAB, PANITUMUMAB, PANTOPRAZOLE SODIUM | DrugsGivenReaction | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated myocarditis'. | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34225811 | 19,602,584 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Klebsiella infection'. | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, METHYLPREDNISOLONE ACETATE, METOPROLOL SUCCINATE, NIVOLUMAB, PANITUMUMAB, PANTOPRAZOLE SODIUM | DrugsGivenReaction | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to liver'. | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, METHYLPREDNISOLONE ACETATE, METOPROLOL SUCCINATE, NIVOLUMAB, PANITUMUMAB, PANTOPRAZOLE SODIUM | DrugsGivenReaction | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to lung'. | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, METHYLPREDNISOLONE ACETATE, METOPROLOL SUCCINATE, NIVOLUMAB, PANITUMUMAB, PANTOPRAZOLE SODIUM | DrugsGivenReaction | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocarditis'. | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | FLUOROURACIL, IRINOTECAN, LEUCOVORIN, METHYLPREDNISOLONE ACETATE, METOPROLOL SUCCINATE, NIVOLUMAB, PANITUMUMAB, PANTOPRAZOLE SODIUM | DrugsGivenReaction | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the administration route of drug 'METOPROLOL SUCCINATE'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Oral | DrugAdministrationRoute | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the dosage of drug 'FLUOROURACIL'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | UNK, SEVEN CYCLES AFTER THE OPERATION | DrugDosageText | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the dosage of drug 'IRINOTECAN'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | UNK, SEVEN CYCLES AFTER THE OPERATION | DrugDosageText | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the dosage of drug 'LEUCOVORIN'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | UNK, SEVEN CYCLES AFTER THE OPERATION | DrugDosageText | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the dosage of drug 'PANITUMUMAB'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | SEVEN CYCLES AFTER THE OPERATION | DrugDosageText | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the outcome of reaction 'Anuria'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Recovered | ReactionOutcome | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the outcome of reaction 'Cardiogenic shock'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Recovered | ReactionOutcome | CC BY | 34225811 | 19,602,584 | 2021-07-06 |
What was the outcome of reaction 'Death'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Fatal | ReactionOutcome | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the outcome of reaction 'Immune-mediated myocarditis'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Recovered | ReactionOutcome | CC BY | 34225811 | 19,602,584 | 2021-07-06 |
What was the outcome of reaction 'Klebsiella infection'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Recovering | ReactionOutcome | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the outcome of reaction 'Metastases to liver'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Recovering | ReactionOutcome | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the outcome of reaction 'Metastases to lung'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Recovering | ReactionOutcome | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
What was the outcome of reaction 'Myocarditis'? | Fulminant myocarditis induced by immune checkpoint inhibitor nivolumab: a case report and review of the literature.
BACKGROUND
Nivolumab, an anti-programmed cell death protein 1 antibody, is commonly used as an immune checkpoint inhibitor in various cancers. Various adverse events are associated with these therapies, i... | Recovering | ReactionOutcome | CC BY | 34225811 | 19,710,731 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diplopia'. | Ocular adverse events in PD-1 and PD-L1 inhibitors.
Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors can cause unique immune-related adverse effects due to non-specific immunological activation. However, less is known about adverse effects of these drugs in the eye.
Two adverse event databa... | CABOZANTINIB S-MALATE, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34226280 | 19,526,670 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Intentional product use issue'. | Ocular adverse events in PD-1 and PD-L1 inhibitors.
Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors can cause unique immune-related adverse effects due to non-specific immunological activation. However, less is known about adverse effects of these drugs in the eye.
Two adverse event databa... | CABOZANTINIB S-MALATE, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34226280 | 20,189,231 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metastases to meninges'. | Ocular adverse events in PD-1 and PD-L1 inhibitors.
Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors can cause unique immune-related adverse effects due to non-specific immunological activation. However, less is known about adverse effects of these drugs in the eye.
Two adverse event databa... | CABOZANTINIB S-MALATE, NIVOLUMAB | DrugsGivenReaction | CC BY-NC | 34226280 | 19,526,670 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cholangitis'. | Liver Transplantation: A 10-Year Low-Volume Transplant Center Experience in Kazakhstan.
BACKGROUND Liver transplantation is considered to be the best available treatment option for patients with liver failure. In Kazakhstan, the liver transplantation program was established a decade ago. In this study, we analyzed a lo... | BASILIXIMAB, MYCOPHENOLATE MOFETIL, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34226437 | 19,933,757 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tumour pseudoprogression'. | Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab.
A 52-year-old man underwent pneumonectomy of the left lung for previously diagnosed primary spindle cell carcinoma (pT4aN1M0, stage III B) with programmed death-ligand 1 expression (tumor proportion score ≥95%) and without epidermal grow... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 34227241 | 19,564,326 | 2021-08 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab.
A 52-year-old man underwent pneumonectomy of the left lung for previously diagnosed primary spindle cell carcinoma (pT4aN1M0, stage III B) with programmed death-ligand 1 expression (tumor proportion score ≥95%) and without epidermal grow... | 200 MG/ BODYWEIGHT, EVERY THREE WEEKS | DrugDosageText | CC BY | 34227241 | 19,564,326 | 2021-08 |
What was the outcome of reaction 'Tumour pseudoprogression'? | Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab.
A 52-year-old man underwent pneumonectomy of the left lung for previously diagnosed primary spindle cell carcinoma (pT4aN1M0, stage III B) with programmed death-ligand 1 expression (tumor proportion score ≥95%) and without epidermal grow... | Recovering | ReactionOutcome | CC BY | 34227241 | 19,564,326 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Factors for Timely Identification of Possible Occurrence of Delirium in Palliative Care: A Prospective Observational Study.
Delirium occurs in 50-80% of end-of-life patients but is often misdiagnosed. Identification of clinical factors potentially associated with delirium onset can lead to a correct early diagnosis. To... | HALOPERIDOL | DrugsGivenReaction | CC BY-NC | 34228345 | 19,598,361 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute hepatic failure'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Candida infection'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Candida test positive'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | ACETYLCYSTEINE, ACTIVATED CHARCOAL, FILGRASTIM, PHENYLEPHRINE HYDROCHLORIDE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, SODIUM BICARBONATE, VANCOMYCIN, VASOPRESSIN | DrugsGivenReaction | CC BY-NC | 34229452 | 19,927,308 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug abuse'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE, HYDROXYZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34229452 | 19,698,972 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'General physical health deterioration'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | ACETYLCYSTEINE, ACTIVATED CHARCOAL, FILGRASTIM, PHENYLEPHRINE HYDROCHLORIDE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, SODIUM BICARBONATE, VANCOMYCIN, VASOPRESSIN | DrugsGivenReaction | CC BY-NC | 34229452 | 19,927,308 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE, HYDROXYZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34229452 | 19,698,972 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic function abnormal'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Left ventricular dysfunction'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Livedo reticularis'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mental status changes'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal haemorrhage'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | ACETAMINOPHEN, BUPRENORPHINE HYDROCHLORIDE\NALOXONE HYDROCHLORIDE, COLCHICINE, HYDROXYZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34229452 | 19,929,210 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory distress'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE, HYDROXYZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34229452 | 19,698,972 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Shock'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE, HYDROXYZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34229452 | 19,698,972 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin discolouration'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE, HYDROXYZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34229452 | 19,698,972 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin exfoliation'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE, HYDROXYZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34229452 | 19,698,972 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Substance abuse'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | ACETAMINOPHEN, BUPRENORPHINE HYDROCHLORIDE\NALOXONE HYDROCHLORIDE, COLCHICINE, HYDROXYZINE HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 34229452 | 19,929,210 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachycardia'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachypnoea'. | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | COLCHICINE | DrugsGivenReaction | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the administration route of drug 'COLCHICINE'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Oral | DrugAdministrationRoute | CC BY-NC | 34229452 | 19,698,972 | 2021 |
What was the administration route of drug 'HYDROXYZINE HYDROCHLORIDE'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Oral | DrugAdministrationRoute | CC BY-NC | 34229452 | 19,698,972 | 2021 |
What was the dosage of drug 'HYDROXYZINE HYDROCHLORIDE'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | UNKNOWN | DrugDosageText | CC BY-NC | 34229452 | 19,698,972 | 2021 |
What was the dosage of drug 'SODIUM BICARBONATE'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | UNK (DRIP) | DrugDosageText | CC BY-NC | 34229452 | 19,927,308 | 2021 |
What was the outcome of reaction 'Abdominal pain'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Accidental overdose'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Acidosis'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Acute hepatic failure'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Blister'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Blood lactic acid increased'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Candida infection'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Death'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 19,927,308 | 2021 |
What was the outcome of reaction 'Diarrhoea'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Disseminated intravascular coagulation'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Generalised oedema'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Hepatic function abnormal'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Hyperkalaemia'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Hyperphosphataemia'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Hypocalcaemia'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Hypoglycaemia'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Hypomagnesaemia'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Hypotension'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Left ventricular dysfunction'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Leukocytosis'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Lipase increased'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Livedo reticularis'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Mental status changes'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Mucosal haemorrhage'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Multiple organ dysfunction syndrome'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 19,698,972 | 2021 |
What was the outcome of reaction 'Nausea'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Neutropenia'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Oliguria'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Overdose'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 19,929,210 | 2021 |
What was the outcome of reaction 'Pancytopenia'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
What was the outcome of reaction 'Rhabdomyolysis'? | The Ugly Side of Colchicine.
We report a rare case of a 32-year-old male who ingested 32.4 to 54 mg of colchicine and presented after 44 hours. He developed progressive multiple organ failure with shock, acute kidney failure, troponemia, pancytopenia, absolute neutropenia, disseminated intravascular coagulation, acute ... | Fatal | ReactionOutcome | CC BY-NC | 34229452 | 20,055,035 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.